Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Payables (2023 - 2025)

Cannabis Bioscience International Holdings' Payables history spans 3 years, with the latest figure at $159217.0 for Q4 2025.

  • For Q4 2025, Payables fell 5.43% year-over-year to $159217.0; the TTM value through Nov 2025 reached $159217.0, down 5.43%, while the annual FY2025 figure was $212065.0, 29.79% down from the prior year.
  • Payables for Q4 2025 was $159217.0 at Cannabis Bioscience International Holdings, up from $107660.0 in the prior quarter.
  • Across five years, Payables topped out at $302052.0 in Q2 2024 and bottomed at $107660.0 in Q3 2025.
  • The 3-year median for Payables is $214697.0 (2023), against an average of $206579.3.
  • The largest annual shift saw Payables rose 29.8% in 2024 before it plummeted 56.75% in 2025.
  • A 3-year view of Payables shows it stood at $217329.0 in 2023, then decreased by 22.53% to $168355.0 in 2024, then fell by 5.43% to $159217.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Payables are $159217.0 (Q4 2025), $107660.0 (Q3 2025), and $212065.0 (Q2 2025).